Chinese Biotechs Feel Chill Wind Of Hesitant Investors

 
• By Dexter Jie Yan

Large or small, Chinese biotechs are receiving the cold shoulder from some investors amid souring investment sentiment. HanBio, Frontier and InnoCare have all seen their fundraising efforts hampered to various degrees.

hesitate
Hesitant investors hampering Chinese biotechs' fundraising efforts • Source: Shutterstock

More from China

More from Focus On Asia